“Molecular Docking Study of α-, β-, and γ-Mangostin from Mangosteen (Garcinia mangostana L.) Targeting VEGFR-2 and NRP-1 for Anti-Angiogenic Therapeutics in Retinopathy Diabetic” (2025) The Eurasia Proceedings of Health, Environment and Life Sciences, 17, pp. 10–21. doi:10.55549/ephels.145.